Jubilant Pharmova announced its US subsidiary, Jubilant HollisterStier LLC, underwent a USFDA inspection. The facility in Spokane, Washingt...

Maharashtra's Food and Drug Administration has issued a significant directive. Hospitals and medical practitioners must now allow patients ...

Dabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data ...

The US Food and Drug Administration has placed Dabur India's factory on an import alert. This action follows an inspection that revealed si...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

The U.S. FDA has identified significant data integrity and manufacturing lapses at a Dabur India plant following a January inspection. Find...

A nationwide recall has been issued for at least eight products sold at ALDI and Walmart , including frozen pizzas and pork rinds, due to p...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

India and New Zealand will sign a Free Trade Agreement on Monday, April 27. This landmark deal aims to boost bilateral trade significantly....

Thane police have clarified a viral video showing a disoriented man. The man was not under the influence of a 'zombie drug'. He had taken a...

In a letter to FDA Commissioner Martin Makary, Banks said the agency must "do more to protect the US drug supply," warning that lax oversig...

Aurobindo Pharma faces scrutiny. The US FDA inspected its Bachupally, Telangana plant. The inspection occurred between August 25 and Septem...

Three top American lawmakers have raised concerns about the FDA's foreign drug inspection program in India and China. In a letter to FDA Co...

The US Food and Drug Administration (FDA) completes inspection of Solara Active Pharma Sciences' API manufacturing facility in Visakhapatna...

With India playing a significant role in the global pharmaceutical sector, one may wonder about the quality control practices adopted in th...

Since the Generic Drug User Fee Amendments implementation in Oct 2012, FDA inspections have doubled in India and China, which led to consid...

The 13-page observation by investigators Massoud Motamed and Latorie Jones noted several deviations that were against good manufacturing pr...